HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David R Nelson Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

10/2017Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.
8/2012Unexpected maintenance of hepatitis C viral diversity following liver transplantation.
8/2011Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David R Nelson Research Topics

Disease

63Infections
10/2022 - 11/2002
45Chronic Hepatitis C
10/2022 - 01/2003
40Fibrosis (Cirrhosis)
11/2023 - 11/2002
33Hepatitis C
01/2021 - 11/2002
16Sepsis (Septicemia)
07/2013 - 07/2003
12Hepatocellular Carcinoma (Hepatoma)
10/2019 - 05/2003
10Liver Diseases (Liver Disease)
05/2024 - 10/2003
8Neoplasms (Cancer)
01/2018 - 03/2004
7End Stage Liver Disease
01/2021 - 05/2006
6Virus Diseases (Viral Diseases)
04/2015 - 01/2003
5Chronic Renal Insufficiency
05/2024 - 05/2006
5Type 2 Diabetes Mellitus (MODY)
06/2023 - 07/2011
5Hepatitis
12/2021 - 11/2002
5Body Weight (Weight, Body)
04/2014 - 10/2008
5Hepatitis B
01/2011 - 08/2005
5Inflammation (Inflammations)
01/2007 - 07/2003
4Fatigue
05/2013 - 09/2010
3Stroke (Strokes)
05/2024 - 01/2018
3Myocardial Infarction
05/2024 - 01/2018
3Tuberculosis (Tuberculoses)
04/2024 - 02/2019
3Obesity
11/2023 - 07/2011
3Disease Resistance
12/2021 - 11/2018
3Substance-Related Disorders (Drug Abuse)
01/2021 - 01/2017
3Liver Cirrhosis (Hepatic Cirrhosis)
10/2017 - 08/2011
3Anemia
11/2013 - 07/2007
3Nausea
05/2013 - 04/2013
3Starvation
05/2013 - 01/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2024 - 11/2002
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2022 - 08/2010
2Lyme Disease (Disease, Lyme)
02/2016 - 01/2010
2Hemolysis
10/2013 - 09/2009
2Hemorrhagic Septicemia (Haemorrhagic Septicemia)
10/2013 - 05/2006
2Neutropenia
06/2013 - 01/2012
2Headache (Headaches)
05/2013 - 05/2013
2Rheumatoid Arthritis
03/2013 - 10/2011
2Persistent Infection
09/2011 - 09/2005
2Liver Neoplasms (Liver Cancer)
04/2011 - 03/2004
2Disease Progression
09/2009 - 10/2003

Drug/Important Bio-Agent (IBA)

36Antiviral Agents (Antivirals)IBA
10/2022 - 11/2002
36Ribavirin (Virazole)FDA LinkGeneric
10/2021 - 11/2002
23InterferonsIBA
09/2019 - 02/2004
20SofosbuvirIBA
12/2019 - 04/2013
12drotrecogin alfa activated (Xigris)FDA Link
05/2011 - 07/2003
10RNA (Ribonucleic Acid)IBA
12/2016 - 11/2002
9Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2000
9Protein CIBA
01/2008 - 05/2004
8AlbuminsIBA
10/2022 - 01/2006
8Protease Inhibitors (Protease Inhibitor)IBA
10/2017 - 01/2011
8Interferon-alpha (Interferon Alfa)IBA
02/2009 - 05/2003
7Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2003
5BilirubinIBA
10/2022 - 12/2016
5NucleotidesIBA
12/2021 - 05/2013
5telaprevirIBA
04/2015 - 09/2011
4sofosbuvir drug combination ledipasvirIBA
01/2022 - 12/2016
4glecaprevir and pibrentasvirIBA
01/2021 - 10/2017
4dasabuvirIBA
01/2019 - 01/2014
4ombitasvirIBA
01/2019 - 01/2014
4paritaprevirIBA
01/2019 - 01/2014
4Ritonavir (Norvir)FDA Link
01/2019 - 01/2014
4daclatasvirIBA
11/2016 - 01/2014
4peginterferon alfa-2a (Pegasys)FDA Link
06/2013 - 10/2008
4Alanine Transaminase (SGPT)IBA
11/2012 - 08/2005
4Interferon alpha-2 (Roferon-A)FDA Link
10/2010 - 11/2002
3Insulin (Novolin)FDA Link
06/2023 - 09/2013
3grazoprevirIBA
01/2022 - 10/2015
3elbasvirIBA
01/2022 - 10/2015
3ledipasvirIBA
11/2018 - 04/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2017 - 11/2007
3N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
02/2015 - 11/2013
3Sorafenib (BAY 43-9006)FDA Link
04/2013 - 04/2011
3Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2011 - 01/2006
3albinterferon alfa-2bIBA
10/2010 - 02/2009
3Human Serum AlbuminFDA LinkGeneric
10/2010 - 01/2006
2CarbonIBA
02/2019 - 01/2003
2DNA (Deoxyribonucleic Acid)IBA
11/2018 - 11/2012
2SimeprevirIBA
01/2018 - 02/2016
2pibrentasvirIBA
10/2017 - 10/2017
2glecaprevirIBA
10/2017 - 10/2017
2CreatinineIBA
02/2015 - 05/2006
2Peptides (Polypeptides)IBA
10/2014 - 10/2010
2TabletsIBA
04/2014 - 04/2014
2Hemolysin Proteins (Hemolysins)IBA
10/2013 - 06/2008
2Rituximab (Mabthera)FDA Link
03/2013 - 01/2010
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
08/2011 - 10/2010
2Phosphotransferases (Kinase)IBA
04/2011 - 08/2004
2Interleukin-10 (Interleukin 10)IBA
08/2010 - 10/2003
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2010 - 01/2006
2ProdrugsIBA
09/2009 - 07/2007
2taribavirin (viramidine)IBA
09/2009 - 07/2007
2Virulence Factors (Pathogenicity Factors)IBA
06/2008 - 05/2006
2Interleukin-6 (Interleukin 6)IBA
01/2007 - 05/2004

Therapy/Procedure

56Therapeutics
01/2021 - 11/2002
23Liver Transplantation
10/2019 - 11/2002
5Transplantation
07/2013 - 01/2005
3Aftercare (After-Treatment)
12/2019 - 02/2004
3Drug Tapering
11/2013 - 02/2009
2Glycemic Control
06/2023 - 01/2018
2Duration of Therapy
01/2021 - 02/2016
2Drug Therapy (Chemotherapy)
04/2015 - 05/2008
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2008 - 01/2006